A Revolutionary Kidney Stone Treatment
No Anesthesia. No Fluoroscopy.
Smarter and More Accessible
At Avvio Medical, we are transforming the standard of care for urinary stone disease with a cutting-edge, office-based procedure that reduces wait times and eliminates the need for fluoroscopy or general anesthesia.
Our innovative technology uses low-pressure ultrasound to activate calcium-seeking microbubbles, creating millions of micro-jets that break down stones. This approach aims to not only enhance patient safety and comfort but also lowers overall medical costs, offering a more accessible solution for stone removal.
Low-Pressure Cavitation Induced Fragmentation of Urinary Stone
Accelerated Timelapse of 5.6 minutes of actual treatment
Minimally Invasive
Our office-based procedure eliminates the need for general anesthesia or fluoroscopy, for a safer experience.
Faster Treatment
Shorter wait times streamline care, allowing for quicker stone removal and patient recovery.
Expanded Access
Procedures can be done in outpatient clinics or rural settings, reducing the need for specialized facilities.
Cost-Effective
The procedure reduces overall medical costs by avoiding expensive imaging and anesthesia.
See how it works
News & Events
See moreAvvio Medical’s Microbubble Technology Reduces Complications and Shows Promise for Enhancing Laser Lithotripsy: AEROLITH Trial Results Published in The Journal of Urology
July 8, 2025 | Uncategorized
San Francisco, CA – July 8, 2025 – Avvio Medical Inc. today announced the publication of its AEROLITH randomized clinical trial in The Journal of Urology. Study highlights were presented at the 2025 American Urological Association (AUA) Annual Meeting in…Avvio Medical Proudly Announces ISO 13485 Certification, Marking a Major Milestone in Global MedTech Readiness
June 26, 2025 | Press Release
San Francisco, CA – June 25, 2025 – Avvio Medical, Inc., a clinical-stage medical device company focused on transforming the treatment of kidney stone disease, is proud to announce that it has successfully achieved ISO 13485:2016 certification following its initial…Avvio Medical Announces First Patients Treated with Groundbreaking Kidney Stone Therapy
May 8, 2025 | Press Release
San Francisco, CA – May 6, 2025 – Avvio Medical, Inc. (formerly Applaud Medical, Inc.) today announced the successful treatment of the first patients using its investigational Enhanced Lithotripsy System (ELS), a pioneering advancement in kidney stone therapy. This milestone…
CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. Avvio Medical, Inc. does not currently offer medical devices for sale or distribution and the company’s technology has not received market clearance status by the U.S. FDA or any other country’s regulatory authority.
MKT-006 Revision O, April 2025.